$20.85
0.160.76%
After Hours: 9:26 AM EDT
Comments
Loading...
Latest Summit Therapeutics Stock News | NASDAQ:SMMT | Benzinga
Get the latest news on Summit Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Summit Therapeutics performance
Categories: All
Monday, March 24, 2025
Friday, March 21, 2025
Sunday, March 16, 2025
Wednesday, March 12, 2025
Friday, February 28, 2025
Thursday, February 27, 2025
Tuesday, February 25, 2025
Monday, February 24, 2025
- Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday?
- Summit Therapeutics shares are trading lower....
- Summit Therapeutics and Pfizer Partner to Adv...
- Summit Therapeutics Q4 2024 Adj EPS $(0.07) B...
- Summit Therapeutics Enters Clinical Trial Col...
- Earnings Scheduled For February 24, 2025
Friday, February 21, 2025
Monday, February 03, 2025
Sunday, January 26, 2025
Tuesday, January 21, 2025
Monday, January 20, 2025
Friday, January 17, 2025
Friday, January 10, 2025
Wednesday, January 08, 2025
Tuesday, January 07, 2025
Monday, December 16, 2024
Friday, December 13, 2024
Wednesday, December 11, 2024
Friday, December 06, 2024
Monday, November 18, 2024
Saturday, November 09, 2024
Monday, November 04, 2024
- Summit Therapeutics 'Unique Investment In Oncology,' Lead Drug Candidate Shows Promise Over Keytruda And Opdivo
- Summit Therapeutics shares are trading higher...
- This Tencent Music Entertainment Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
- JMP Securities Initiates Coverage On Summit T...